Anne M. O. Griffiths

Anne M. O. Griffiths's AcademicInfluence.com Rankings

Biology

#7255

World Rank

#10149

Historical Rank

Computational Biology

#134

World Rank

#134

Historical Rank

Genetics

#688

World Rank

#774

Historical Rank

Molecular Biology

#818

World Rank

#838

Historical Rank

biology Degrees

Download Badge

Biology

Anne M. O. Griffiths's Degrees

PhD Genetics University of Oxford

Why Is Anne M. O. Griffiths Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anne M. O. Griffiths's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (2006) (2867)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008) (2621)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci (2010) (2516)
The treatment-naive microbiome in new-onset Crohn's disease. (2014) (2269)
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis (2007) (1825)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) (1315)
Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification (2011) (1160)
Development and validation of a pediatric Crohn's disease activity index. (1991) (1004)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. (2014) (837)
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends (2011) (832)
Functional variants of OCTN cation transporter genes are associated with Crohn disease (2004) (825)
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease (2001) (820)
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. (2007) (783)
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. (2007) (696)
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. (2015) (564)
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. (2007) (535)
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. (2000) (532)
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. (2020) (529)
Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America (2007) (487)
Common variants at five new loci associated with early-onset inflammatory bowel disease (2009) (479)
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. (2014) (402)
Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. (1995) (396)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study (2017) (390)
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data (2009) (380)
What really happens to people on long-term peritoneal dialysis? (1998) (364)
Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines (2012) (352)
Specificities of inflammatory bowel disease in childhood. (2004) (351)
Association of host genome with intestinal microbial composition in a large healthy cohort (2016) (330)
Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience (2005) (299)
Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. (2011) (297)
The minimal detectable change cannot reliably replace the minimal important difference. (2010) (283)
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. (2014) (275)
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. (2009) (268)
Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort (2006) (264)
Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. (1996) (261)
Role of infant feeding practices in development of Crohn's disease in childhood. (1989) (259)
High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis (2014) (250)
Growth and clinical course of children with Crohn's disease. (1993) (249)
Hepatosplenic T‐cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale? (2007) (243)
Alterations in the gut microbiome of children with severe ulcerative colitis (2012) (242)
Appraisal of the pediatric ulcerative colitis activity index (PUCAI) (2009) (241)
Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases (2017) (235)
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. (2012) (235)
IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis (2013) (234)
The IMPACT Questionnaire: A Valid Measure of Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease (2002) (227)
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. (2010) (225)
Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. (2012) (223)
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. (2014) (212)
Corticosteroids for maintenance of remission in Crohn's disease. (2003) (211)
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. (2020) (206)
Guidelines for the management of growth failure in childhood inflammatory bowel disease. (2008) (201)
Ulcerative colitis loci on chromosomes 1p36 and 12q15 identified by genome-wide association study (2008) (199)
Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis (1995) (199)
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases (2015) (193)
Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN (2011) (193)
Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions (2012) (189)
Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease (2009) (187)
Traditional corticosteroids for induction of remission in Crohn's disease. (2008) (186)
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. (2009) (185)
Enteral nutritional therapy for induction of remission in Crohn's disease. (2007) (178)
Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. (2010) (177)
Budesonide for induction of remission in Crohn's disease. (2008) (175)
Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. (2014) (175)
Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses (2011) (173)
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. (2017) (169)
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 (2011) (162)
A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. (2009) (161)
Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy (2007) (160)
Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease (2007) (157)
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition (2018) (153)
Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. (2002) (153)
Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements (2012) (150)
Severe Ulcerative Colitis After Rituximab Therapy (2010) (148)
Enteral nutritional therapy for inducing remission of Crohn's disease. (2001) (146)
Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohn's Disease (2007) (145)
Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms (2009) (142)
Tufting enteropathy: a newly recognized clinicopathological entity associated with refractory diarrhea in infants. (1994) (141)
The natural history of corticosteroid therapy for ulcerative colitis in children. (2006) (140)
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (139)
Oral tacrolimus treatment of severe colitis in children. (2000) (138)
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity (2010) (137)
Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease (2009) (133)
Mechanisms of growth impairment in pediatric Crohn's disease (2009) (133)
Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. (2018) (130)
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn’s Disease (2009) (129)
Laboratory Values for Children With Newly Diagnosed Inflammatory Bowel Disease (2007) (127)
Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response (2010) (127)
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease (2008) (126)
Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease (2015) (125)
Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination (2007) (125)
Outcome Following Infliximab Therapy in Children With Ulcerative Colitis (2010) (122)
Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. (2007) (117)
Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis (2011) (116)
Appraisal of the Pediatric Crohn's Disease Activity Index on Four Prospectively Collected Datasets: Recommended Cutoff Values and Clinimetric Properties (2010) (116)
Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease (2007) (115)
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. (2006) (114)
CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease (2004) (113)
Transcriptional Risk Scores link GWAS to eQTL and Predict Complications in Crohn's Disease (2017) (111)
Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. (1999) (109)
Factors influencing postoperative recurrence of Crohn's disease in childhood. (1991) (109)
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. (2008) (105)
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. (2007) (103)
Assessing activity of pediatric Crohn's disease: which index to use? (1999) (102)
Acute severe ulcerative colitis in children: A systematic review (2011) (102)
Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. (2014) (100)
Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype (2009) (99)
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD (2018) (99)
Health‐related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease (2006) (98)
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension (2011) (97)
Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohn's Disease (2009) (96)
Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease. (2020) (94)
Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease. (2020) (94)
Defects in Nicotinamide-adenine Dinucleotide Phosphate Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease (2015) (92)
Development of an index to define overall disease severity in IBD (2016) (92)
Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. (2000) (89)
Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. (2009) (89)
Oral budesonide for induction of remission in ulcerative colitis. (2010) (88)
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care- an Evidence-Based Guideline from ECCO and ESPGHAN. (2018) (87)
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (2018) (86)
Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. (2015) (85)
Budesonide for induction of remission in Crohn's disease. (2015) (84)
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study (2019) (84)
Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease. (2016) (84)
Infant feeding practices and ulcerative colitis in childhood. (1991) (84)
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. (2014) (83)
Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease (2018) (80)
Factors that determine risk for surgery in pediatric patients with Crohn's disease. (2010) (80)
Gastral Antral Biopsy in the Differentiation of Pediatric Colitides (2003) (78)
Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994–2007)1,2 (2011) (77)
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease. (2015) (76)
Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohn's Disease (2014) (76)
A Critical Assessment of Items on the Pediatric Crohn's Disease Activity Index (2003) (75)
Methotrexate for maintenance of remission in ulcerative colitis. (2015) (74)
Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. (2011) (74)
A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease. (2009) (74)
Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study (2017) (73)
Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms (2013) (73)
Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology And Nutrition. (2004) (72)
Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. (2001) (72)
Corrigendum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study (2009) (71)
Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH (2009) (71)
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. (2011) (70)
Intercenter variation in initial management of children with Crohn's disease (2007) (70)
Relationship of Common Laboratory Parameters to the Activity of Crohn's Disease in Children (1992) (70)
A Review of Activity Indices and End Points for Clinical Trials in Children with Crohn's Disease (2005) (69)
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. (1998) (68)
Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. (2000) (68)
Systematic review with meta‐analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease (2015) (66)
Acute cytomegalovirus infection in a child with Ménétrier's disease. (1995) (64)
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease? (2017) (64)
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee (2014) (64)
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. (2011) (63)
Perianal complications of pediatric Crohn's disease. (1991) (63)
Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Multicenter, Open-label, Phase 3 Study (2013) (62)
Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis (2007) (61)
Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. (1993) (61)
Outcome Following Thiopurine Use in Children With Ulcerative Colitis: A Prospective Multicenter Registry Study (2011) (61)
Neutrophil dysfunction in glycogen storage disease Ib: association with Crohn's-like colitis. (1991) (60)
Genetic sharing and heritability of paediatric age of onset autoimmune diseases (2015) (59)
Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. (2019) (59)
Growth Retardation in Early-Onset Inflammatory Bowel Disease: Should We Monitor and Treat These Patients Differently? (2009) (58)
Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. (2017) (58)
Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. (2020) (57)
Budesonide for maintenance of remission in Crohn's disease. (2014) (56)
Effects of Serum From Children with Newly Diagnosed Crohn Disease on Primary Cultures of Rat Osteoblasts (2002) (56)
Clinical Outcomes With Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis (2018) (56)
Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. (2013) (55)
Slow‐Release 5‐Aminosalicylic Acid Therapy in Children with Small Intestinal Crohn's Disease (1993) (55)
Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated with Monogenic Variants, Identified by Whole-exome Sequencing in 1000 Children at a Single Center. (2020) (55)
Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis (2007) (55)
Oral budesonide for induction of remission in ulcerative colitis. (2015) (54)
Pediatric Crohn Disease Activity Index: Responsive to Short-term Change (2003) (54)
Outcome after ileoanal anastomosis in pediatric patients with ulcerative colitis. (1998) (53)
Gut microbiome in primary sclerosing cholangitis: A review (2020) (52)
Clinical value of fecal calprotectin (2019) (50)
Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. (1998) (49)
The IBD and PSC Phenotypes of PSC-IBD (2018) (49)
Asymptomatic Uveitis in Children with Chronic Inflammatory Bowel Diseases (1993) (48)
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children. (2018) (47)
Determinants of Intestinal Permeability in Healthy First-Degree Relatives of Individuals with Crohn's Disease (2015) (47)
Pico-Salax versus polyethylene glycol for bowel cleanout before colonoscopy in children: a randomized controlled trial. (2009) (47)
Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease. (2018) (47)
Enteral nutrition in the management of Crohn's disease. (2005) (46)
Controlled Ileal Release Budesonide in Pediatric Crohn Disease: Efficacy and Effect on Growth (2001) (46)
Clinical Features of Gastroduodenal Crohn's Disease in Adolescents (1989) (46)
Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed As Having Ulcerative Colitis (2013) (46)
Toxic Megacolon in Children With Inflammatory Bowel Disease: Clinical and Radiographic Characteristics (2008) (45)
Struggles, strengths, and strategies: an ethnographic study exploring the experiences of adolescents living with an ostomy (2008) (44)
Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease. (2018) (44)
Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis (2014) (44)
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease. (2012) (43)
Assessing disease activity in ulcerative colitis: Patients or their physicians? (2010) (43)
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis. (2013) (43)
Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes. (1989) (43)
The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada (2018) (42)
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. (2009) (42)
Design Issues and Outcomes in Ibd Clinical Trials (2005) (42)
Ketotifen Therapy for Acute Ulcerative Colitis in Children (A Pilot Study) (1998) (41)
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis; An Evidence-based Consensus Guideline from ECCO and ESPGHAN. (2018) (40)
Keeping an eye on Crohn's disease: orbital myositis as the presenting symptom. (1997) (40)
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers. (2015) (39)
Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping (2015) (39)
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) (2007) (39)
Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis (2010) (39)
Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease. (2011) (38)
Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis (2018) (38)
Acrodermatitis enteropathica with normal serum zinc levels: diagnostic value of small bowel biopsy and essential fatty acid determination. (1989) (38)
Factors associated with early outcomes following standardized therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study (2017) (38)
Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn’s disease and associated with decreased height (2017) (37)
Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study (2018) (37)
Type I interferons for induction of remission in ulcerative colitis. (2008) (36)
Pediatricians Overestimate Importance of Physical Symptoms Upon Children’s Health Concerns (2002) (36)
FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects (2018) (36)
Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in Children (2018) (36)
Phenotype-Stratified Genetic Linkage Study Demonstrates that IBD2 Is an Extensive Ulcerative Colitis Locus (2006) (35)
Levels of Peptidoleukotriene E4 Are Elevated in Active Crohn's Disease (1995) (35)
Fecal osteoprotegerin may guide the introduction of second‐line therapy in hospitalized children with ulcerative colitis (2011) (35)
Quality of Life in Inflammatory Bowel Disease: A Cross-Cultural Comparison of English and Canadian Children (2001) (35)
Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. (1997) (35)
IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. (2016) (34)
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network (2016) (33)
Enteral nutrition: the neglected primary therapy of active Crohn's disease. (2000) (32)
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. (2017) (32)
Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohn's Disease (2014) (32)
Mucus sialylation determines intestinal host-commensal homeostasis (2022) (31)
Collagenous colitis and eosinophilic gastritis in a 4‐year old girl: a case report and review of the literature (2007) (31)
Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2009) (31)
Efficacy of oral methotrexate in paediatric Crohn’s disease: a multicentre propensity score study (2014) (31)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (31)
Utility of Neutrophil Fc&ggr; Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease (2014) (31)
Serum Antibodies Associated with Complex Inflammatory Bowel Disease (2013) (30)
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease. (2019) (30)
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program. (2020) (30)
9 RELAPSE PREVENTION/GROWTH ENHANCEMENT IN PEDIATRIC CROHN'S DISEASE: MULTICENTER RANDOMIZED CONTROLLED TRIAL OF INTERMITTENT ENTERAL NUTRITION VERSUS ALTERNATE DAY PREDNISONE. (1996) (30)
Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit (2017) (29)
Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (2020) (29)
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. (2019) (29)
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary (2019) (29)
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis (2017) (29)
Corticosteroids for maintaining remission of Crohn's disease. (2000) (29)
Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis (2018) (29)
A Prospective Multicenter Study: Development and Validation of a Pediatric Ulcerative Colitis Activity Index (2006) (28)
Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. (2019) (27)
Phenotypic variation in paediatric IBD by age: a multi-centre prospective inception cohort study of the Canadian Children IBD Network. (2020) (27)
Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn’s Disease (2017) (27)
Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease (2015) (24)
A Systematic Review of Monogenic Inflammatory Bowel Disease. (2021) (24)
Perianal Pediatric Crohn Disease Is Associated With a Distinct Phenotype and Greater Inflammatory Burden (2018) (24)
Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease. (2019) (24)
Inflammatory Bowel Disease: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition (2004) (23)
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease (2018) (23)
The Effect of Early‐Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children (2018) (23)
A comparison of two methods of dietary assessment in peritoneal dialysis patients. (1999) (23)
Genetic profiling in inflammatory bowel disease: from association to bedside. (2011) (22)
Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease: A Position Paper from The Paediatric IBD Porto Group of ESPGHAN. (2020) (22)
Benefit of oral immune globulin therapy in patients with immunodeficiency and chronic diarrhea. (1991) (21)
Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease (2017) (21)
Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort (2018) (21)
Nutrition in inflammatory bowel disease (2000) (21)
Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis (2010) (21)
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease (2019) (21)
Impact of Peritoneal Membrane Function on Long Term Clinical Outcome in Peritoneal Dialysis Patients (1999) (20)
Budesonide for Crohn's disease (2009) (20)
Enteral feeding in inflammatory bowel disease (2006) (20)
Impact-iii Is a Valid, Reliable and Responsive Measure of Health-related Quality of Life in Pediatric Crohn's Disease (2006) (19)
Pathological features of multiple endocrine neoplasia type IIb in childhood. (1990) (19)
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients (2021) (19)
Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration (2018) (18)
Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease (2017) (18)
Enteric Protein Loss Measured by Fecal α1Antitrypsin Clearance in the Assessment of Crohn's Disease Activity: A Study of Children and Adolescents (1986) (18)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Paneth cell marker CD24 in NOD2 knockout organoids and in inflammatory bowel disease (IBD) (2013) (17)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative Colitis. (2018) (17)
Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. (2015) (17)
Liver Enzyme Elevations Within 3 Months of Diagnosis of Inflammatory Bowel Disease and Likelihood of Liver Disease (2014) (17)
Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study. (2019) (17)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation (2021) (16)
Fibronectin and immune complexes in rheumatic diseases. (1987) (16)
Replication of genetic variation in the MYO9B gene in Crohn's disease. (2011) (16)
Intensified infliximab induction is associated with improved response and decreased colectomy in steroid-refractory paediatric ulcerative colitis. (2019) (16)
Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. (2020) (16)
Age-of-Diagnosis Dependent Ileal Immune Intensification and Reduced Alpha-Defensin in Older versus Younger Pediatric Crohn Disease Patients despite Already Established Dysbiosis (2018) (16)
Diagnostic Delay Is Associated with Complicated Disease and Growth Impairment in Paediatric Crohn's Disease. (2020) (16)
Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis. (2018) (16)
Type I interferons for induction of remission in ulcerative colitis. (2015) (16)
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey (2020) (16)
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases is Associated with Milder Clinical Activity but More Frequent Subclinical Inflammation and Growth Impairment. (2020) (15)
Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach. (2009) (15)
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study (2021) (15)
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29 (2008) (15)
Mediterranean-like dietary pattern associations with gut microbiome composition and sub-clinical gastrointestinal inflammation. (2022) (15)
Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: A Propensity Score Analysis (2016) (14)
Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. (2018) (14)
Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. (2021) (14)
Medical Therapy for Pediatric Inflammatory Bowel Disease (2012) (14)
Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study (2017) (14)
New Onset Autoimmune Hepatitis during Anti‐Tumor Necrosis Factor‐Alpha Treatment in Children (2017) (14)
The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World (2018) (13)
Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations (2015) (13)
Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252)) (2011) (13)
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program. (2020) (12)
Use of LARA-urea breath test in the diagnosis of Helicobacter pylori infection in children and adolescents: a preliminary study. (2003) (12)
Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls. (2020) (12)
Genome-wide association study identifies five novel susceptibility loci for Crohn ' s disease and implicates a role for autophagy in disease pathogenesis (2009) (11)
Review and clinical perspectives for the use of infliximab in ulcerative colitis. (2008) (11)
Prioritizing Crohn’s disease genes by integrating association signals with gene expression implicates monocyte subsets (2019) (11)
Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis (2019) (11)
Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles. (2018) (11)
Simple Endoscopic Score of Crohn's disease and Magnetic Resonance Enterography in Children: Report from ImageKids study. (2019) (11)
Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects (2020) (11)
Can MR enterography screen for perianal disease in pediatric inflammatory bowel disease? (2018) (11)
Induction and Maintenance Adalimumab Therapy for the Treatment of Moderate to Severe Crohn's Disease in Children (2011) (11)
Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease. (2020) (11)
One‐year outcomes with ustekinumab therapy in infliximab‐refractory paediatric ulcerative colitis: a multicentre prospective study (2021) (10)
Severe neutropenia following infliximab treatment in a child with ulcerative colitis. (2011) (10)
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease (2021) (10)
Hypothesis-free analysis of ATG16L1 demonstrates gene-wide extent of association with Crohn's disease susceptibility (2012) (10)
Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study (2021) (10)
41 Serious Infections and Associated Risk Factors in Patients Receiving Infliximab and Immunotherapies for Children With Inflammatory Bowel Disease: Develop Registry Data (2013) (10)
Abdominal X-ray in Pediatric Acute Severe Colitis and Radiographic Predictors of Response to Intravenous Steroids (2016) (9)
Characterizing the Posttransfer Period Among Patients with Pediatric Onset IBD: The Impact of Academic Versus Community Adult Care on Emergent Health Resource Utilization. (2017) (9)
833 Malignancies in Children Receiving Infliximab and Other Inflammatory Bowel Disease Therapies: An Inflammatory Bowel Disease Multicenter, Prospective, Long-Term Registry of Pediatric Patients (Develop) Registry Data (2013) (9)
Accurate classification of pediatric colonic IBD subtype using a random forest machine learning classifier. (2020) (9)
INFLIXIMAB THERAPY RESTORES NORMAL GROWTH IN CHILDREN WITH CHRONICALLY ACTIVE SEVERE CROHN DISEASE REFRACTORY TO IMMUNOMODULATORY THERAPY: PG2-17 (2005) (9)
Characterizing the Posttransfer Period Among Patients with Pediatric Onset IBD: The Impact of Academic Versus Community Adult Care on Emergent Health Resource Utilization. (2017) (8)
Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease. (2022) (8)
Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC) (2017) (8)
Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis (2009) (8)
Multiple endocrine neoplasia IIb: an unusual cause of chronic constipation. (1990) (7)
Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey (2019) (7)
Intervention for Growth Failure in Children with IBD (2006) (7)
An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease (2021) (7)
Sa1816 – Elevated Fecal Calprotectin in Healthy First Degree Relatives of Patients with Crohn's Disease is Associated with Future Diagnosis of Crohn's Disease (2019) (7)
Growth Impairment in Pediatric Inflammatory Bowel Disease (2013) (7)
Cost-effectiveness and Clinical Outcomes of Early Anti-Tumor Necrosis Factor-α Intervention in Pediatric Crohn's Disease. (2019) (7)
ORAL TACROLIMUS TREATMENT OF SEVERE COLITIS IN CHILDREN: LONG-TERM FOLLOWUP (1998) (6)
A Simple Endoscopic Score Modified for the Upper Gastrointestinal Tract in Crohn’s Disease [UGI-SES-CD]: A Report From the ImageKids Study (2018) (6)
Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network—A Joint Partnership of CIHR and the CH.I.L.D. Foundation (2017) (6)
Engaging Patients and Caregivers in Research for Pediatric Inflammatory Bowel Disease: Top 10 Research Priorities. (2019) (6)
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases (2022) (6)
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. (2021) (6)
Fecal Markers of Inflammation and Disease Activity in Paediatric Crohn's Disease: Results from the ImageKids Study. (2019) (6)
Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease. (2018) (6)
Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease. (2020) (6)
Body Composition Using Air Displacement Plethysmography in Children With Inflammatory Bowel Disease. (2020) (6)
Enteral feeding and Crohn disease (2001) (6)
6 Crohn's disease in adolescents (1998) (6)
P-046: Damage and inflammatory activity in pediatric Crohn’s disease (CD) based on radiologist and gastroenterologist physician global assessment (2014) (5)
Vitamin D deficiency enhances expression of autophagy-regulating miR-142-3p in mouse and 'involved' IBD patient intestinal tissues. (2021) (5)
Appraisal of the PIBD-classes criteria: a multicenter validation. (2020) (5)
A RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INFLIXIMAB IN PEDIATRIC PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: 148* (2005) (5)
Engaging Patients and Caregivers in Research for Pediatric IBD: Top 10 Research Priorities. (2019) (5)
Challenging Question: Can We Diagnose Crohn's Disease without Histology? (2013) (5)
P0719 EPIDEMIOLOGY OF PEDIATRIC IBD IN THE GREATER TORONTO AREA (2004) (5)
Corticosteroids for maintaining remission of Crohn's disease. (2001) (4)
Enteral nutrition in children. (1999) (4)
Corrigendum: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (4)
S1189 Upper Gastrointestinal Involvement in Pediatric Crohn's Disease: Experience of a Large Multicenter Inception Cohort (2010) (4)
A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis (2011) (4)
W1219 Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (Reseat) in Pediatric Crohn's Disease (2008) (4)
Factors that influence the postoperative recurrence of Crohn’s disease in childhood (1990) (4)
P515 Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: A pilot randomised controlled trial (2018) (4)
P128 Development of the Paediatric Inflammatory Crohn's MRE Index (PICMI)- results from the ImageKids Study (2018) (4)
Incidence of Inflammatory Bowel Disease in South Asian and Chinese People: A Population-Based Cohort Study from Ontario, Canada (2021) (4)
Budesonide Use in Pediatric Crohn Disease (2012) (4)
Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease. (2021) (4)
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease (2021) (4)
W1177 Infliximab-Induced Psoriasis in Pediatric Crohn Disease; Experience of This Paradoxical Skin Manifestation At a Tertiary Centre and a Potential Association with a Variation in the IL-23r Gene (2009) (4)
The phenotypic spectrum of new onset IBD in Canadian children of South Asian ethnicity: A prospective multi-centre comparative study. (2021) (4)
Methotrexate for maintenance of remission in ulcerative colitis. (2009) (4)
Outcomes Following Aminosalicylate Therapy in Children Newly Diagnosed With Ulcerative Colitis: A Prospective Multi-Center Registry Experience (2011) (4)
Prevalence of NOD2/CARD15 mutations in pediatric IBD (2003) (4)
Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: con. Why use a drug with an unknown long-term safety profile if more established therapies will be effective? (2001) (3)
Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results (2020) (3)
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study (2017) (3)
Sa1151 Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial (2014) (3)
Contribution of HLA class II genes to susceptibility to ulcerative colitis (UC) in a Canadian inflammatory bowel disease (IBD) population (1998) (3)
96 – Increased Intestinal Permeability is a Predictor of Crohn's Disease Development in a Large Cohort of Asymptomatic First Degree Relatives (2019) (3)
P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data (2013) (3)
Analysis of Using the Total White Blood Cell Count to Define Severe New Onset Ulcerative Colitis in Children. (2020) (3)
Thiopurine Monotherapy in Paediatric Inflammatory Bowel Disease: 20 Years After Markowitz. (2020) (3)
CROHN'S DISEASE IN CHILDREN AND ADOLESCENTS : WHAT ARE THE TREATMENT OPTIONS? (1999) (3)
Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE (2021) (3)
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America (2022) (3)
Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn’s and Colitis Canada (2022) (3)
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary (2021) (3)
DEVELOPMENT OF A PEDIATRIC ULCERATIVE COLITIS ACTIVITY INDEX (PUCAI) (2006) (3)
Infliximab-induced psoriasis in pediatric Crohn Disease; Experience of this paradoxical event at a tertiary centre: P-0043. (2008) (3)
Magnetic Resonance Enterography Cannot Replace Upper Endoscopy in Pediatric Crohn Disease: An Imagekids Sub-study (2017) (3)
What's Hot in the Red Journal This Month? (2009) (3)
Growth Impairment in Children (2008) (3)
W1181 Long-Term Efficacy and Safety of Maintenance Infliximab for the Treatment of Moderate-to-Severe Pediatric Crohn's Disease: Results from the Reach Study (2009) (3)
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations (2021) (3)
T1745 A Prospective Multicenter Study of Outcomes and Predictors of Response in Severe Pediatric Ulcerative Colitis (2009) (3)
Osteopenia is frequent in children with Crohn's disease at diagnosis (1999) (3)
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents (2022) (3)
Prospective Evaluation of Endoscopic and Histologic Indices in Pediatric Ulcerative Colitis Using Centralized Review (2021) (2)
Lifestyle Issues in Children and Adolescents with Chronic Inflammatory Bowel Diseases (1990) (2)
Phenotypic Evolution of Pediatric Inflammatory Bowel Disease Using the New Paris Classification (2011) (2)
Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody: clinical tools or clues for research? (2000) (2)
Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study. (2021) (2)
RESPONSE TO CORTICOSTEROIDS IN SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND A META-REGRESSION (2006) (2)
Stratification of Risk of Progression to Colectomy in Ulcerative Colitis using Measured and Predicted Gene Expression (2021) (2)
Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease: Associations With Adalimumab Exposure (2021) (2)
850a The treatment-naive microbiome in early-onset Crohn's Disease (2014) (2)
Corrigendum: Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2010) (2)
631 A Multi-Center Open-Label Study Assessing Pharmacokinetics, Efficacy, and Safety of Subcutaneous Golimumab in Pediatric Patients With Moderately-Severely Active Ulcerative Colitis (2016) (2)
Crohn's disease in adolescents. (1998) (2)
P0712 RE-EVALUATION OF THE PEDIATRIC CROHN???S DISEASE ACTIVITY INDEX: USEFULNESS IN THE PRACTICE SETTING (2004) (2)
Quality of Life in Paediatric Crohn’s Disease: Data From the Imagekids Study (2016) (2)
CONTRIBUTION OF DLG5, MDR1, NOD1/CARD4 AND TLR4 TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2006) (2)
Differentiation of Colonic Inflammatory Bowel Disease: Re-examination of Paediatric Inflammatory Bowel Disease Classes Algorithm With Resected Colon As the Criterion Standard. (2020) (2)
629 Risk of Malignancy in Pediatric Inflammatory Bowel Disease: Results From the DEVELOP Registry (2016) (2)
A systematic review of MR enterography signs of inflammation and damage in Crohnʼs disease: P-149. (2011) (2)
Explorer Single Nucleotide Polymorphisms That Increase Expression of the Guanosine Triphosphatase RAC 1 Are Associated With Ulcerative Colitis (2011) (2)
The Effects of Infliximab Therapy on Health-Related Quality of Life in Pediatric Crohnʼs Disease (2006) (2)
Contribution of Various Susceptibility Genes to Pediatric-onset IBD (2006) (2)
Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel (2016) (2)
Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease. (2004) (2)
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. (2007) (2)
Erratum: Phenotypic and genotypic characteristics of inflammatory bowel disease in french canadians: Comparison with a large North American repository (Am J Gastroenterol (2009) 104 (2233-2240) (DOI: 10.1038/ajg.2009.267) (2010) (2)
P188 A systematic review of MR enterography signs of inflammation and damage in Crohn's disease (2012) (2)
MACHINE LEARNING FOR CROHN’S DISEASE PHENOTYPE MODELING USING BIOPSY IMAGES (2021) (2)
M1146 The Ontario Crohn's & Colitis Cohort: Validation of An Algorithm to Identify Children Diagnosed with Inflammatory Bowel Disease Using Health Administrative Data (2009) (2)
Development, validation and evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index (PICMI) from the ImageKids study. (2022) (2)
Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort (2018) (2)
847v 18 New Crohn's Disease Susceptibility Genes and Loci Identified by the International IBD Genetics Consortium (2010) (2)
630 Intensification of Infliximab Induction Regimen Improves Response Rate in Steroid-Refractory Pediatric Ulcerative Colitis (2016) (1)
An explanation for growth impairment in chronic inflammation. (1999) (1)
O-11: Real world outcomes of contemporary treatments in children with Crohn’s disease: observations from the pediatric IBD collaborative research group registry (2014) (1)
CHARACTERIZATION OF THE NONCOLLAGENOUS RETICULIN COMPONENT OF HUMAN-TISSUES (1986) (1)
X-Linked Inhibitor of Apoptosis Protein (XIAP) Genetic Variants in Paediatric-Onset IBD (2017) (1)
829 Early Anti-TNFα Therapy Is Superior to Early Immunomodulator Therapy in Newly Diagnosed Children With Crohn's Disease (2013) (1)
DOES HAVING A FAMILY HISTORY OF INFLAMMATORY BOWEL DISEASE AFFECT QUALITY OF LIFE IN NEWLY DIAGNOSED CHILDREN? (2006) (1)
The Need for Evidence-Based Care in the Daily Practice of Pediatric Gastroenterology (1999) (1)
Time for Personalized Biologic Therapy: One Size Does Not Fit All. (2016) (1)
OC-010 Detailed analysis of ATG16L1 demonstrates gene-wide extent of association with crohn's disease susceptibility (2012) (1)
Improvement in a biomarker of bone formation during infliximab therapy in pediatric Crohn disease: Results of the REACH study (2007) (1)
A26 PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE INCREASES THE RISK OF VENOUS THROMBOEMBOLISM: A CANGIEC POPULATION-BASED STUDY (2020) (1)
CONTRIBUTION OF SUSCEPTIBILITY GENES TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE: 204 (2005) (1)
O-16: MRE cannot replace gastroscopy (EGD) in assessing the upper gastrointestinal tract in pediatric Crohn’s disease (CD): results from the ImageKids study (2014) (1)
31 Putative Genetic Loci and Confirmation of Association in IBD (2010) (1)
O-009 Long ncRNA Landscape in the Ileum of Treatment Naïve Early Onset Crohn Disease (2017) (1)
P-0047: Low income children with Inflammatory Bowel Disease have higher surgical and hospitalization rates in a Universal Health Care System (2009) (1)
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. (2022) (1)
Long Term Outcomes with Adalimumab Therapy in Pediatric Crohn's Disease (2021) (1)
Initial response to treatment (Rx) and need for intensified (step-up) therapy in children with newly diagnosed, inflammatory bowel disease (IBD): A preliminary investigation by the pediatric IBD collaborative research group (2003) (1)
A85 IMPROVING OUTCOMES IN THE PEDIATRIC TO ADULT CARE TRANSITION IN IBD (IMPACT IBD) (2019) (1)
IMPACT-II QOL questionnaire: Performance in new-onset pediatric IBD patients (the pediatric IBD collaborative registry) (2003) (1)
149 A Prospective Multicenter Study: Outcomes and Predictors of Response to Infliximab Given as a Rescue Therapy in Severe Pediatric Ulcerative Colitis (2010) (1)
Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress (2021) (1)
138 Effect of Deep Ulceration at Diagnostic Colonoscopy on Initial Therapy and One Year Outcome in Children With Crohn's Disease (2012) (1)
P0666 LAB PARAMETERS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD) AT DIAGNOSIS (2004) (1)
P-072: Growth improvement in adalimumab-treated paediatric patients with Crohn’s disease: data from IMAgINE 1 (2014) (1)
S1290 Efficacy, Safety, and Pharmacokinetics of Infliximab Dose Escalation in Pediatric Patients With Crohn’s Disease or Ulcerative Colitis: An Analysis of the DEVELOP Registry (2021) (1)
T1164 Surgery in a Prospectively Followed Cohort of Pediatric Patients with Crohn's Disease (CD) (2008) (1)
DOP71 Efficacy, safety, and tolerability of ustekinumab in paediatric patients with moderately to severely active Crohn’s disease: Results from, UniStar, a phase 1 study (2020) (1)
Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn’s Disease (2021) (1)
Inflammatory bowel disease in children in sub-Saharan Africa (2020) (1)
Thiopurine Monotherapy in Paediatric Inflammatory Bowel Disease: 20 Years After Markowitz. (2020) (1)
Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary. (2003) (1)
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy (2021) (1)
Falk Symposium Series (2009) (1)
Early Anti-TNF is Effective in Preventing Internal Penetrating but not Stricturing Disease Complications in Children Newly Diagnosed with Crohn's Disease: A Prospective Risk Prediction Model for Disease Behavior Study (2017) (1)
A178 USTEKINUMAB FOLLOWING PRIMARY ANTI-TNF FAILURE AND SECONDARY LOSS OF RESPONSE TO VEDOLIZUMAB IN AN ADOLESCENT WITH ULCERATIVE PANCOLITIS (2021) (1)
259 Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects (2013) (1)
P192 - Disease duration does not affect outcome following infliximab therapy in children with Crohn's disease (2009) (1)
A Model for Bacterial-Mediated Changes of the Mucosal Barrier in IBDs: Campylobacter jejuni Infection Impairs the Integrity of Polarized Epithelial Cells (2006) (1)
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis (2021) (1)
391 Two Novel Polysaccharide Antibodies (Anti-Laminarin and Anti-Chitin) Predict An Aggressive Crohn's Disease Phenotype and Improve Differentiation Between Crohn's Disease and Ulcerative Colitis (2008) (1)
W1188 Growth in Pediatric Patients with IBD Treated with Infliximab or 6-Mercaptopurine/Azathioprine (2009) (1)
Disease Duration Does Not Affect Outcome Following Infliximab in Children with Crohnʼs Disease: 1360 (2008) (1)
ENTERIC PROTEIN LOSS, MEASURED BY FECAL ALPHA-1-ANTI-TRYPSIN (AT) CLEARANCE, IN THE ASSESSMENT OF CROHN'S DISEASE ACTIVITY (1984) (1)
Fibronectin andimmunecomplexes inrheumatic diseases (1987) (1)
Sa1884 Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease (2012) (1)
506 Outcome Following Thiopurine use in Children With Ulcerative Colitis: A Prospective Multicenter Study (2010) (1)
3.17 Enteral Nutrition in Inflammatory Bowel Disease (2008) (1)
P044 Identifying Children Diagnosed with IBD Using Health Administrative Data: Development of the Ontario Crohn's and Colitis Cohort (OCCC) (2009) (1)
More on lymphoproliferative disorders associated with crohn disease treatments. (2013) (1)
Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease (2020) (1)
Su2017 - Predicting Response to Standardized Pediatric Colitis Therapy: The Protect Study (2018) (1)
DOP58 IdeaL: a multi-centre prospective infliximab dose to level pharmacokinetic study during induction in paediatric Crohn’s disease (2019) (1)
Early Use of Therapeutic Drug Monitoring to Individualize Infliximab Therapy in Paediatric IBD: A Multicentre Prospective Cohort Study (2017) (1)
953 Prolonged Exposure to Prednisone Is Decreasing in Children With Inflammatory Bowel Disease (IBD) During the Last Decade (2013) (1)
Improvement in Markers of Bone Metabolism with Adalimumab in Children with Moderately to Severely Active Crohnʼs Disease: Results from IMAgINE 1: 2049 (2013) (1)
A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease (2023) (1)
DOP039 Development of MRE based multi item measures of inflammation and intestinal damage in paediatric Crohn's disease: the ImageKids study (2014) (1)
Supplementary enterai nutrition maintains remission in paediatric Crohn's disease (1996) (1)
PATTERNS OF INFLIXIMAB USE IN CHILDREN WITH CROHN DISEASE (2006) (1)
Differentiation of Colonic IBD: Re-examination of PIBD Classes Algorithm With Resected Colon As Gold Standard. (2019) (1)
81 Prevalence of Inflammatory Bowel Disease in First-Degree Relatives of Children with IBD. (1996) (1)
139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease (2012) (1)
692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease (2013) (1)
Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con. (2005) (1)
Development of a multimodal machine-learning fusion model to non-invasively assess ileal Crohn's disease endoscopic activity (2022) (1)
P-097 A Multicenter Open-Label Study Assessing Pharmacokinetics, Efficacy, and Safety of Subcutaneous Golimumab in Pediatric Subjects with Moderately-Severely Active Ulcerative Colitis (2016) (1)
P283 Predicting outcomes in paediatric Crohn’s disease: A systematic review (2018) (1)
Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent. (2023) (0)
O06 Infliximab-Induced Psoriasis in Paediatric Crohn Disease; Experience at a Tertiary Centre and a Potential Association with a Variation in the IL-23 Receptor Gene (2009) (0)
Changing trends in growth abnormalities in children with IBD: A preliminary investigation by the pediatric IBD collaborative research group (2003) (0)
Su1854 - Ethnic Variation of Pediatric Inflammatory Bowel Disease in Canada (2018) (0)
Long‐term Outcomes With Infliximab Treatment in Children With Crohn's Disease at a Single Centre: P‐144 YI (2012) (0)
A260 HEALTH-RELATED QUALITY OF LIFE IMPACT OF STEROIDS VS. EXCLUSIVE ENTERAL NUTRITION FOR INDUCTION IN A LARGE CANADIAN PEDIATRIC IBD INCEPTION COHORT (2019) (0)
204 – Surgery in Very Early Onset Inflammatory Bowel Disease (Veoibd): Results from a Large, Multi-Center North American Cohort (2019) (0)
A30 ETHNIC VARIATION OF PEDIATRIC INFLAMMATORY BOWEL DISEASE IN CANADA (2018) (0)
Table 2 Canadian association of Gastroenterology (CaG)-Canadian Institutes of Health Research (CIHR) Partner-Funded grants 2011 (2011) (0)
Sa1906 – Dose Escalation with Originator Infliximab is More Common Than Standard Dosing in Pediatric IBD – the Develop Experience (2019) (0)
Genes and Microbes Linked at Last (2001) (0)
A CROSS-CULTURAL COMPARISON OF QUALITY OF LIFE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (1999) (0)
831 Prospective Cohort Study of Methotrexate Use in Treatment of Pediatric Crohn Disease (2013) (0)
Changing Trends in Pharmacologic Therapy of Pediatric Crohn's Disease (2011) (0)
A238 ALTERED GUT MICROBIOME COMPOSITION AND FUNCTION ARE ASSOCIATED WITH GUT BARRIER DYSFUNCTION IN HEALTHY RELATIVES OF CROHN’S DISEASE PATIENTS (2022) (0)
601 INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE (2021) (0)
VALIDATION OF A DISEASE-SPECIFIC INSTRUMENT TO EVALUATE HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PAEDIATRIC IBD (1998) (0)
S1213 Comparative Characteristics of Inflammatory Bowel Disease (IBD) in Individuals of South Asian, Jewish and Caucasian Ethnic Backgrounds (2010) (0)
880 – Delineating the Phenotype of Pediatric Psc-Ibd Using Longitudinal Data Analysis (2019) (0)
Pediatric Inflammatory Bowel Disease in the Emergency Department (2010) (0)
Higher Mucosal Calprotectin Expression is Associated with Induction of Antimicrobial and Tumor Necrosis Factor Alpha Signaling and Reduced Effectiveness of Corticosteroid Therapy in Treatment Naive Pediatric Ulcerative Colitis (2017) (0)
378 - Genomic Correlates of Reduced Neutrophil Granulocytemacrophage Colony Stimulating Factor Signaling in Stricturing Pediatric Crohn Disease (2018) (0)
Crohn ' s disease . Growth and clinical course of children with (2006) (0)
O-28: New biologicals, mechanism of action (2010) (0)
Is Mesalamine Monotherapy Equally Effective in Inducing Remission in Mild Versus Moderate Pediatric Ulcerative Colitis at Diagnosis (2017) (0)
nduction and Maintenance Infliximab Therapy for the Treatment of oderate-to-Severe Crohn ’ s Disease in Children (2007) (0)
Su1878 - Serum Markers can Predict Future Fibrostenotic Complications at the Time of Diagnosis in Pediatric Crohn's Disease (2018) (0)
Innate dysregulation and growth failure in Pediatric Crohn Disease: O-8. (2011) (0)
Identification of two novel susceptibility loci in a Canadian inflammatory bowel disease population (2000) (0)
P503 Early TNF-antagonist maintenance therapy results in better outcomes than immunomodulators in paediatric Crohn’s disease: A multi-centre prospective cohort study (2022) (0)
694 Age Specific Genetic Variations in Very Early Onset Inflammatory Bowel Disease (2013) (0)
S2003 Serum Vitamin D Level and Disease Activity in Pediatric Inflammatory Bowel Disease (2010) (0)
A112 EARLY USE OF THERAPEUTIC DRUG MONITORING TO INDIVIDUALIZE INFLIXIMAB THERAPY IN PAEDIATRIC IBD: A MULTICENTRE PROSPECTIVE COHORT STUDY (2018) (0)
30. Parliament and Petitions (2018) (0)
P460 Early use of therapeutic drug monitoring to individualize infliximab therapy in paediatric IBD: a multicentre prospective COHORT study. (2017) (0)
A182 PREDICTING HIGH DIRECT HEALTHCARE COSTS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE FIRST YEAR FOLLOWING DIAGNOSIS (2023) (0)
Indirect and Out-of-Pocket Disease-associated Costs in Pediatric Inflammatory Bowel Disease: A Cross-sectional Analysis (2022) (0)
Budesonide for the Induction of Remission in Crohnʼs Disease: Update of a Systematic Review and Meta-analysis for the Cochrane Collaboration: 1827 (2013) (0)
Greater Contribution of HLA to Risk for Pediatric-Onset Ulcerative Colitis Can be Narrowed to 3 Independent Classic HLA Variants and Corresponding Amino Acid Changes (2017) (0)
33 The GTPase RAC1 is Associated With Inflammatory Bowel Disease (2010) (0)
A65 VARIATION IN THE CARE OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A CANGIEC POPULATION-BASED STUDY (2020) (0)
P632 Estimating indirect and out-of-pocket disease-associated costs in paediatric Inflammatory Bowel Disease: a nation-wide cross-sectional analysis (2022) (0)
NADPH oxidase complex and IBD Candidate Gene studies: O-18. (2011) (0)
Su1519: DEVELOPMENT AND VALIDATION OF THE TUMMY-UC, A PATIENT-REPORTED OUTCOME IN PEDIATRIC ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE STUDY (2022) (0)
REDUCTION IN FISTULA IN INFLIXIMAB TREATED PATIENTS: OBSERVATIONS FROM REACH (2006) (0)
P470 Infliximab treatment for paediatric Crohn's disease: long-term outcomes at a single centre (2013) (0)
A genome-wide scan in a canadian inflammatory bowel disease (IBD) population reveals two novel susceptibility loci (2000) (0)
Sensitivity of Multiple Breath Washout and Spirometry for Detection of Early Lung Disease in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis: A Multicenter Study (2019) (0)
Long Term Use of Adalimumab in Pediatric Crohnʼs Disease: A Multi-Center Study: 1458 (2009) (0)
P127 An assessment of a pancolonic adaptation of the ulcerative colitis endoscopic index of severity in comparison to clinical and biochemical markers of disease activity in paediatric ulcerative colitis. (2017) (0)
Mo1773 Variation in the Treatment of New Onset Pediatric IBD Among Phenotypically Similar Patient Subgroups in Canada: A Cross-Sectional Analysis of the Canadian Children IBD Network Inception Cohort (2016) (0)
Su2020 - Higher Post-Induction Infliximab Serum Trough Levels are Associated with Healing of Fistulizing Peri-Anal Crohn's Disease in Children (2018) (0)
82 Outcome Following Colectomy and Ileoanal Anastomosis in Paediatric Patients with Ulcerative Colitis. (1996) (0)
W1187 Outcome Following Infliximab Therapy in Pediatric Patients with Ulcerative Colitis: Results from a Multicenter Study (2009) (0)
Genetic susceptibility in a Canadian inflammatory bowel disease (IBD) population (1998) (0)
Tu1693 Liver Injury Associated with Anti-TNF Therapy in Pediatric IBD (2016) (0)
497 - Irrespective of Initial Ulcerative Colitis Therapy Thiopurines Unlikely to Result in Corticosteroid-Free Remission One Year after Diagnosis (2018) (0)
Guideline for the Medical Management of Pediatric Luminal Crohn ’ s Disease (2019) (0)
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2022) (0)
Medical therapy of paediatric inflammatory bowel disease (2022) (0)
589 - The Treatment Naive Rectal Transcriptome Identifies Pathways Mediating Clinical and Endoscopic Severity and Response to Initial Therapy in Pediatric Ulcerative Colitis (2018) (0)
615 PHARMACOKINETICS OF USTEKINUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY (2020) (0)
Tu1190 Clinical Outcome and Prediction of Final Diagnosis in Pediatric Inflammatory Bowel Disease Unclassified (IBD-U) Patients (2014) (0)
Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study (2022) (0)
Sa1989 Pharmacokinetics of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis: Results From a Randomized, Multicenter, Open-Label Phase 3 Study (2012) (0)
Biological interventions for maintenance of mucosal healing in Crohn’s disease (2017) (0)
498 - Defining Remission in Pediatric Ulcerative Colitis: Evidence from the Protect Study (2018) (0)
Sa1159 Development of MRE Based Multi Item Measures of Inflammation and Intestinal Damage in Paediatric Crohn's Disease: The ImageKids Study (2014) (0)
Su1219 GUT MICROBIAL STRAINS AND METABOLITES IN DISEASE COURSE OF PEDIATRIC ULCERATIVE COLITIS (2020) (0)
P0615 STEROID THERAPY IN THE AGE OF INFLIXIMAB (IFX): IMMEDIATE AND 1 YEAR OUTCOME IN NEWLY DIAGNOSED CHILDREN WITH CROHN DISEASE (CD) (2004) (0)
Can we Simplify the Pediatric Ulcerative Colitis Index to the Point of Patient-Reported Outcomes Only? (2017) (0)
P268 Fecal calprotectin correlates more highly with endoscopic disease activity than symptom-based disease activity markers in paediatric PSC-IBD. (2017) (0)
Suboptimal Early Outcomes following Standardized Induction Therapy in Children Newly Diagnosed with Ulcerative Colitis: The Protect Study (2017) (0)
P0687 CHARACTERIZATION OF HEIGHT AND WEIGHT PATTERNS IN NEWLY DIAGNOSED CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD) (2004) (0)
P170 Diagnostic criteria for IBD subtype classification: a multi-centre validation cohort (2019) (0)
A189 EMERGENCY DEPARTMENT UTILIZATION AND RISK OF INTESTINAL RESECTION IS LOWER AMONG CHILDREN DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BEFORE 10 YEARS OF AGE: A MULTIPROVINCE POPULATION-BASED COHORT STUDY (2023) (0)
180 CLINICAL CHARACTERISTICS, CLINICAL RESPONSE, AND CLINICAL REMISSION STATUS IN ADULTS TREATED WITH USTEKINUMAB IN THE PHASE 3 UNITI STUDIES AT WEEK 6 AND WEEK 44 BY AGE AT CROHN'S DISEASE ONSET (2021) (0)
W1128 Extra-Intestinal Manifestations of Pediatric Inflammatory Bowel Disease (2008) (0)
A166 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA (2021) (0)
Prioritizing Crohn’s disease genes by integrating association signals with gene expression implicates monocyte subsets (2019) (0)
P0128 PP CONTRIBUTION OF CARD15 AND IBD5 (5Q31) LOCI TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2004) (0)
985: COMPARISON OF ONE-YEAR OUTCOMES BETWEEN ADALIMUMAB AND INFLIXIMAB IN CHILDREN WITH LUMINAL CROHN'S DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY (2022) (0)
Su1234 Histologic Correlates of Clinical and Endoscopic Severity in Newly Diagnosed Pediatric Ulcerative Colitis: The PROTECT Study (2015) (0)
ENERGY EXPENDITURE, CYTOKINES AND THERMOGENIC HORMONES IN CHILDREN WITH CROHN'S DISEASE: 6 (1997) (0)
Biological interventions for induction of mucosal healing in Crohn’s disease (2017) (0)
A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS (2022) (0)
O05 Epidemiology of Growth Impairment in Paediatric IBD (2009) (0)
IDENTIFYING RELEVANT PATHWAYS AND BIOMARKERS IN CROHN’S DISEASE USING CONTEXTUALIZED METABOLIC NETWORK MODEL (2021) (0)
838 A Locus on Chromosome 8q24 Near MYC and Anti-OmpC Are Associated With Perianal Crohn's Disease (2013) (0)
587 - Whole Exome Sequencing of over 1000 Pediatric IBD Patients from a Single Centre on an Expanded Gene Panel Identifies Monogenic Forms of IBD (2018) (0)
Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis (2018) (0)
What's Hot in the Red Journal This Month (2011) (0)
441 Endoscopic Assessment of Mucosal Activity in Pediatric Ulcerative Colitis: Are Current Methods Reliable? (2014) (0)
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis (2023) (0)
Predictive testing for Inflammatory Bowel Diseases: The views of unaffected siblings: P-0080. (2009) (0)
Predicting Non-Response to Intravenous Corticosteroid Induction Therapy in Children Newly Diagnosed with Severely Active Ulcerative Colitis: The Protect Study (2017) (0)
Reply (1990) (0)
Imputing missing patient-level data and propensity score matching in cost-effectiveness analysis in Crohn's disease (2021) (0)
Su1391 Infliximab Therapy in Pediatric Crohn's Disease: Results From Develop, A Multicenter Prospective Inflammatory Bowel Disease Registry (2014) (0)
Sa469 PERFORMANCE OF THE SHORT PEDIATRIC CROHN'S DISEASE ACTIVITY INDEX (SPCDAI) AS A CLINICAL EFFECTIVENESS ENDPOINT (2021) (0)
P675 A locus on chromosome 8q24 near MYC and anti-OmpC are associated with perianal Crohn's disease (2013) (0)
Title : Fecal microbial transplantation for pediatric ulcerative colitis : are we there yet ? Invited Commentary on : Fecal microbial transplant in children with ulcerative colitis , randomized double blinded placebo-controlled pilot study (2017) (0)
Understanding and enjoyment (1959) (0)
988: EARLY TNF-ANTAGONIST MAINTENANCE THERAPY RESULTS IN SUPERIOR OUTCOMES COMPARED TO IMMUNOMODULATORS IN PAEDIATRIC CROHN'S DISEASE: A MULTI-CENTRE PROSPECTIVE COHORT STUDY (2022) (0)
PERIANAL FISTULAE IN PEDIATRIC CROHN DISEASE: THERAPIES AND COURSE (2006) (0)
P365 Biological interventions for induction and maintenance of mucosal healing in Crohn’s disease: A Cochrane systematic review (2018) (0)
Clinical Symptoms Correlate Poorly with Endoscopic Inflammation in Pediatric PSC-IBD (2017) (0)
O-29: Oral versus subcutaneous methotrexate (MTX) in pediatric Crohn’s disease (CD): a multicenter propensity score (PS) study (2014) (0)
140 Anti-Microbial Serology Patterns in 824 Children With Newly Diagnosed Crohn's Disease: Association With GM-CSF Auto-Antibodies and Specific Clinical Phenotypes (2012) (0)
W1127 Clinical Outcome Following Immunomodulator Therapy in Pediatric Ulcerative Colitis (UC): Results from a Prospective Multicenter Inception Cohort (2008) (0)
Advanced Techniques for Diagnosis of IBD (2013) (0)
Endothelins and the color of mice: unraveling the etiopathogenesis of Hirschsprung's disease. (1995) (0)
Reply to Dr. Filik's letter (2012) (0)
The effects of Infliximab therapy on health-related quality of life in pediatric crohnʼs disease: P-0071 (2007) (0)
924 Long-Term Outcome Following Infliximab Therapy in Pediatric Patients with Crohn Disease: Results from a Multicenter Study (2008) (0)
27 CLINICAL AND GENOMIC CORRELATES OF NEUTROPHIL GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR SIGNALING IN PEDIATRIC CROHN DISEASE (2018) (0)
P655 Pharmacokinetics of ustekinumab in children and adolescents with moderately to severely active Crohn’s disease: Results from UniStar, a phase 1 study (2020) (0)
Review Section Index, Volume 34 (2009) (0)
Usefulness of Single Balloon Enteroscopy in Pediatric Crohn's Disease (2011) (0)
148 The Gut Microbiome in Children With Severe Ulcerative Colitis (2010) (0)
A157 DEFINITIONS OF MEDITERRANEAN DIET INCONSISTENTLY ASSOCIATE WITH MARKERS OF GUT BARRIER FUNCTION OR SUBCLINICAL INFLAMMATION IN A POPULATION-BASED COHORT (2022) (0)
P754 X-linked inhibitor of apoptosis protein genetic variants in paediatric-onset inflammatory bowel disease. (2017) (0)
634 Serologic Reactivity Reflects Clinical and Genetic Expression of Ulcerative Colitis in Children. The Protect Study (2016) (0)
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. (2022) (0)
Development of a machine-learning model to assess terminal ileum Endoscopic healing in pediatric Crohn's disease from Magnetic Resonance Enterography data (2021) (0)
A86 CHARACTERIZING THE POST-TRANSFER PERIOD AMONGST PATIENTS WITH PEDIATRIC ONSET IBD: THE IMPACT OF ACADEMIC VS. COMMUNITY ADULT CARE ON EMERGENT HEALTH RESOURCE UTILIZATION (2018) (0)
A39 HEALTHY FIRST-DEGREE RELATIVES FROM MULTIPLEX FAMILIES VERSUS SIMPLEX HARBOR A HIGHER RISK OF DEVELOPING CROHN'S DISEASE AND ARE ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION (2023) (0)
Agreement on Symptoms Between Children With Ulcerative Colitis and Their Caregivers: Towards Developing the TUMMY-UC (2021) (0)
A17 LINEAR GROWTH IMPAIRMENT IN CANADIAN CHILDREN PRESENTING WITH NEW ONSET IBD: A MULTI-CENTRE INCEPTION COHORT STUDY (2018) (0)
Su1921 The Great Continental Divide: Anti-TNF Therapy Practice Patterns in Pediatric IBD Differ Significantly in North America Compared to Other Parts of the World (2016) (0)
Prospective validation of the Lémann Index in children: a report from the multicenter ImageKids study. (2023) (0)
Su1195 Simple Blood Testing Defines Severe New Onset Ulcerative Colitis in Children: The PROTECT Study (2015) (0)
Tu1791 - An Expression Based Risk Score for Prediction of Colectomy in Pediatric Ulcerative Colitis (2018) (0)
Microbial Dysbiosis Associated with Disease Severity in Treatment Naive Pediatric Patients with New-Onset Ulcerative Colitis (2017) (0)
UTILIZATION OF WHOLE EXOME SEQUENCING DATA TO IDENTIFY CLINICALLY RELEVANT PHARMACOGENOMIC VARIANTS IN INFLAMMATORY BOWEL DISEASE (2021) (0)
Tu1756 – The Treatment Naive Rectal Transcriptome Identifies Pathways Underlying Response to Induction Corticosteroid Therapy in Ulcerative Colitis (2019) (0)
Tu1744 The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease (2013) (0)
Improvement in a Biomarker of Bone Formation during Infliximab Therapy in Pediatric Crohnʼs Disease: Results of the REACH Study (2006) (0)
P133 Cognitive debriefing interviews (phase 2B) towards developing a Patient Reported Outcome measure for Paediatric ulcerative colitis- the TUMMY-UC (2018) (0)
A93 POST-INDUCTION INFLIXIMAB TROUGH LEVELS VARY WIDELY AND AID IN INDIVIDUALIZING INFLIXIMAB MAINTENANCE THERAPY FOR PEDIATRIC IBD (2018) (0)
Enteral Nutrition in Crohn's Disease in Childhood (2001) (0)
740 - Age-of-Onset Dependent Ileal Immune Maturation and Reduced Alpha-Defensin in Pediatric Crohn Disease with Already Established Dysbiosis (2018) (0)
X. Challenges update workgroups (2008) (0)
INFLAMMATORY BOWEL DISEASE SEROLOGIC MARKERS IN CHILDREN; CORRELATION WITH CLINICAL FINDINGS: A REPORT BY THE PEDIATRIC IBD COLLABORATIVE GROUP: 173* (2005) (0)
M1151 Outcomes After Ileal Resection in Paediatric Crohn Disease: A 30 Year Single Center Experience (2008) (0)
Su1120: LONG NCRNA LANDSCAPE IN THE RECTUM OF TREATMENT NAÏVE EARLY ONSET ULCERATIVE COLITIS HIGHLIGHTS ASSOCIATION WITH SEVERITY AND EARLY AND LATE DISEASE OUTCOME, WITH POTENTIAL ROLE IN EPITHELIAL METABOLIC FUNCTIONS (2022) (0)
W1224 Genotypic Overlap Between Crohn's Disease (CD) and Ulcerative Colitis (UC) in a Large Cohort of Patients With Inflammatory Bowel Disease (IBD) (2010) (0)
Su1980 THE GEM PROJECT: IMPAIRED GUT BARRIER FUNCTION IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CROHN'S DISEASE EVEN IN THE PRESENCE OR ABSCENCE OF PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S PATIENTS (2020) (0)
A176 UTILITY OF MACHINE LEARNING FOR SERUM METABOLOMIC DATA ANALYSIS IN PEDIATRIC CROHN DISEASE (2022) (0)
W1198 Medication Use and Disease Characteristics in Early-Onset and Later-Onset Pediatric Inflammatory Bowel Disease (IBD) (2009) (0)
A267 IDENTIFYING ENTEROBACTERIACEAE VIRULENCE GENES ASSOCIATED WITH ACTIVE DISEASE IN ULCERATIVE COLITIS PATIENTS USING CULTURE-DEPENDENT AND -INDEPENDENT APPROACHES (2023) (0)
Immune determinants of linear growth failure in pediatric Crohn disease: O-003. (2008) (0)
Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial (2022) (0)
P204 Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study (2022) (0)
142 Prospective Multicenter Pediatric Cohort Study: Patients With Liver Enzyme Elevations in the First 3 Months After Diagnosis of Inflammatory Bowel Disease are at Increased Risk of Chronic Liver Disease (2012) (0)
1107 Gene Expression Profiles Associated with Lack of Response to Intravenous Corticosteroids in Children with Severe Ulcerative Colitis (2009) (0)
P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease (2023) (0)
935 PRE-TREATMENT MUCOSAL INFLAMMATORY AND WOUND HEALING GENE PROGRAMS REVEAL MECHANISMS ASSOCIATED WITH FUTURE STRICTURING BEHAVIOR DURING FIVE YEAR FOLLOW-UP IN PEDIATRIC CROHN'S DISEASE (2020) (0)
3.18 Enteral nutrition for paediatric inflammatory bowel disease. (2015) (0)
BODY MASS INDEX (BMI) OF IBD CHILDREN AT DIAGNOSIS; THE EFFECTS OF OBESITY EPIDEMIC: 826 (2004) (0)
54 High Frequency of Non-Classical Endoscopic Findings in Children and Adolescents Diagnosed With UlcerativE.ColiTis. The Protect Study (2017) (0)
Meta-analysis of Omega-3 (Fish Oil) Treatment for Maintaining Remission in IBD (2006) (0)
1161 CLINICAL AND HOST BIOLOGICAL FACTORS CAN PREDICT COLECTOMY RISK IN CHILDREN NEWLY DIAGNOSED WITH ULCERATIVE COLITIS (2020) (0)
Su2027 - Phenotypic Variation in Pediatric IBD by Age: A Multi-Centre Inception Cohort Study of the Canadian Children IBD Network (2018) (0)
Discontinuation of immunomodulator therapy in infliximab-treated children with Crohn disease; one year outcome evaluating influences on disease activity and infliximab antibody formation: P-051. (2008) (0)
Low Neutrophil Reactive Oxygen Species Production is Associated with Nicotinamide-Adenine Dinucleotide Phosphate (NADPH) Oxidase Gene Mutations and Refractory Colonic Involvement in Pediatric Crohn Disease (2017) (0)
NUTRITIONAL STATUS, HABITUAL PHYSICAL ACTIVITY AND QUALITY OF LIFE IN PATIENTS RECEIVING CHRONIC PERITONEAL DIALYSIS. (1998) (0)
A238 BILE ACID COMPOSITION AND DIETARY FAT: IMPLICATIONS FOR CROHN’S DISEASE IN A COHORT OF HEALTHY FIRST-DEGREE RELATIVES (2023) (0)
M1226 Fecal Osteoprotegerin Predicts the Need for Second Line Therapy in Hospitalized Children With Ulcerative Colitis (2010) (0)
P899 Analysis of IL-23 receptor genetic variants associations with gut microbiome composition and barrier function in a cohort of healthy first-degree relatives of subjects with Crohn's disease (2023) (0)
Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option? (2022) (0)
Su2018 - Longitudinal Adherence to Mesalamine in Pediatric Ulcerative Colitis: Results from the Protect Study (2018) (0)
Linear growth during infliximab therapy: Results of the REACH multicenter study: O-0015. (2007) (0)
Author Index / Subject Index (2013) (0)
DEVELOPMENT OF A DISEASE-SPECIFIC INSTRUMENT TO EVALUATE QUALITY OF LIFE IN PAEDIATRIC IBD. (1998) (0)
A103 PHENOTYPIC VARIATION IN PEDIATRIC IBD BY AGE: A MULTI-CENTRE INCEPTION COHORT STUDY OF THE CANADIAN CHILDREN IBD NETWORK (2018) (0)
P-0018: Severe neutropenia following a single infliximab infusion in a child with Crohn disease (2009) (0)
The hunt for inflammatory bowel disease susceptibility genes: where are linkage studies taking us? (1999) (0)
21 Surgery in Pediatric Crohn's Disease, 2002-2014 (2016) (0)
Codes and Courts (1998) (0)
97 Detailed Analysis of ATG16L1 Demonstrates Gene-Wide Extent of Association With Crohn's Disease Susceptibility (2012) (0)
Fecal Microbial Transplantation for Pediatric Ulcerative Colitis: Are We There Yet? (2017) (0)
DOP90 Physician global assessment of IBD Activity is associated with COVID-19 severity in patients aged less than 50 years (2021) (0)
Sa1583: SERUM PROTEOMIC MARKERS THAT PREDICT FUTURE CROHN'S DISEASE DEVELOPMENT ARE ASSOCIATED WITH GUT BARRIER FUNCTION, SUBCLINICAL GUT INFLAMMATION AND IMMUNE RESPONSE TO BACTERIAL ANTIGENS (2022) (0)
A Machine Learning Approach to Identifying Causal Monogenic Variants in Inflammatory Bowel Disease (2022) (0)
Sa1745 - Biological Interventions for Induction and Maintenance of Mucosal Healing in Crohn's Disease: A Cochrane Systematic Review (2018) (0)
A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY (2023) (0)
Inflammatory Bowel Disease (2009) (0)
W1189 Indeterminate Colitis (IC) in Children: A Two-Year Follow-Up (2009) (0)
P700 The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives (2022) (0)
Reduced Transcription of Genes Regulating Mitochondrial Biogenesis is Associated with Poor Response to Corticosteroid Therapy in Newly Diagnosed Pediatric Ulcerative Colitis (2017) (0)
1050 Which Non-Invasive Disease Activity Index Should Be Used in Ulcerative Colitis? A Systematic Head-to-Head Psychometric Comparison (2009) (0)
W1196 Utilization and Effect of Methotrexate in the Treatment of Pediatric Crohn's Disease: A Multi-Center Experience (2009) (0)
154 Inter-Center Variation in the Clinical Outcomes of Pediatric Crohn's Disease (2009) (0)
02 NEW ONSET AUTOIMMUNE DISORDERS, PRIMARILY PSORIASIS, IN ANTI-TNF BIOLOGIC EXPOSED PEDIATRIC PATIENTS – THE DEVELOP EXPERIENCE (2019) (0)
398 THE GEM PROJECT: IDENTIFICATION OF A SERUM PROTEOMIC SIGNATURE ASSOCIATED WITH RISK OF FUTURE CROHN'S DISEASE ONSET IN A COHORT OF HEALTHY AT-RISK INDIVIDUALS (2020) (0)
P671 Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: Results from the UniStar study long-term extension (2023) (0)
ASSESSMENT OF DISEASE ACTIVITY IN CHILDREN WITH CROHN'S DISEASE: CDAI VERSUS PAEDIATRIC CROHN'S DISEASE ACTIVITY INDEX (PCDAI). (1998) (0)
Predicting Response to Oral Corticosteroid Induction Therapy in Children Newly Diagnosed with Moderately Active Ulcerative Colitis: The Protect Study (2017) (0)
834 Ileal Transcriptome Analysis Reveals Mucosal Immune Maturation With Increasing Age-of-Onset in Pediatric Crohn Disease and Healthy Controls - A Mucosal Gene Expression Based Signature That Supports the Paris Classification for Age-of-Onset (2013) (0)
Tu1760 – Alterations in Expression Quantitative Trait Loci from Diagnosis to Recovery in Pediatric Ulcerative Colitis (2019) (0)
Is elemental essential? (1992) (0)
Post-Intestinal Resection Management of Pediatric Crohn's Disease (2011) (0)
Fibronectin fragments in rheumatoid arthritis (1989) (0)
P177 Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic review (2018) (0)
78 Host Ileal APOA1 and DUOX2 Co-Expression Modules Are Associated With Microbial Shifts and Clinical Outcomes in Treatment Naive Pediatric Crohn Disease (2014) (0)
A164 IDENTIFYING THE MOST IMPORTANT PREDICTORS TO CORRELATE SERUM METABOLITES WITH MRE CHANGES IN PATIENTS WITH PEDIATRIC CROHN DISEASE (2023) (0)
Evolution of the phenotypic characteristics of pediatric Inflammatory Bowel Disease using the Paris classification: P-143. (2011) (0)
Getting the NOD to Move Ahead (2001) (0)
P543 Higher post-induction infliximab serum trough levels are associated with healing of fistulising perianal Crohn’s disease in children (2018) (0)
A role for activated T cells in osteoporosis in Crohn disease (2003) (0)
A218 ASSOCIATIONS BETWEEN ADHERENCE TO LITERATURE-DERIVED DIETARY INDICES AND PRE-DISEASE BIOMARKERS: IMPLICATIONS FOR CROHN’S DISEASE PREVENTION (2023) (0)
1164 EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDY (2020) (0)
780 HOST SEROREACTIVITY TO MICROBIAL ANTIGENS IS ASSOCIATED WITH FUTURE ONSET OF CROHN'S DISEASE INDEPENDENT OF GUT BARRIER FUNCTION, SUBCLINICAL INFLAMMATION, AND GENETIC RISK (2021) (0)
health administrative data bowel disease in Ontario, Canada: evidence from Increasing incidence of paediatric inflammatory (2009) (0)
Predicting Response to Mesalamine Induction Therapy in Children Newly Diagnosed with Mild-to-Moderate Ulcerative Colitis: The Protect Study (2017) (0)
Determinants of corticosteroid-resistance in severe pediatric ulcerative colitis: P-0038. (2009) (0)
Sa1996 Crohn's Disease Associated NOD2 Variants Show Differential Activation of NFkB in Response to Autosignaling and Muramyl Dipeptide (2012) (0)
P-216 Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Pediatric IBD Network (2017) (0)
961 Long-Term Outcome of Children With Crohn's Disease: Results From a Large Multi-Center North American Inception Cohort (2014) (0)
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (0)
634 - Gut Microbial Factors Implicated in Disease Progression and Treatment Response in Pediatric Ulcerative Colitis (2018) (0)
W1225 Budesonide Is An Effective But Underutilized Therapy in Pediatric Crohn Disease (2008) (0)
Su1795 – Utilization of Anti-TNF Therapy (BIOLOGICS) in Children with Very Early Onset Inflammatory Bowel Disease (Veoibd) in a Large North American Cohort (2019) (0)
Exploring the reliability of phenotypic assignment for pediatric inflammatory bowel disease. (2011) (0)
P009 Determinants of Corticosteroid-Resistance in Severe Pediatric Ulcerative Colitis (2009) (0)
O04 Incidence and Prevalence of Childhood-Onset Inflammatory Bowel Disease in Ontario, Canada: Results from the Ontario Crohn's and Colitis Cohort (OCCC) (2009) (0)
P-214 YI Early Use of Therapeutic Drug Monitoring to Individualize Infliximab Therapy in Paediatric IBD, a Multicentre Prospective Study (2017) (0)
Sa2011-Novel Candidate Genes in Esophageal Atresia/Tracheoesophageal Fistula Identified by Whole Exome Sequencing (2018) (0)
Changing patterns in pediatric-onset Crohn's disease: A 30 year epidemiologic study (2000) (0)
P572 Half of children with acute severe colitis have predominant single faecal bacterial species, mostly Escherichia coli: Microbiome results from the PRASCO trial (2019) (0)
PTU-092 Crohn's disease associated NOD2 variants show differential activation of NF-κb in response to auto-signalling and muramyl dipeptide (2012) (0)
A228 EVOLUTION OF MRE FINDINGS IN PAEDIATRIC PATIENTS WITH SMALL BOWEL CROHN’S DISEASE ON MAINTENANCE METHOTREXATE (2020) (0)
Five-year incidence of surgery in a prospectively followed cohort of pediatric patients with Crohnʼs Disease: P-0069. (2009) (0)
793: ENVIRONMENTAL FACTORS ASSOCIATED WITH RISK OF CROHN'S DISEASE DEVELOPMENT IN A PROSPECTIVE COHORT OF HEALTHY FIRST-DEGREE RELATIVES OF CD PATIENTS (2022) (0)
Sa504 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA (2021) (0)
A198 THE LONG-TERM IMPACT OF ENVIRONMENTAL EXPOSURES ON HOST HEALTH AND THE RISK FACTORS OF CROHN'S DISEASE (2023) (0)
Sa2001 Longitudinal Assessment of Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease (2012) (0)
Traditional corticosteroids for induction of remission in Crohn disease: a systematic review and meta-analysis: P-004. (2008) (0)
Linear Growth During Infliximab Therapy: Results of the REACH Multicenter Study (2006) (0)
A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION (2022) (0)
Development and validation of the TUMMY-UC, a Patient Reported Outcome for Pediatric Ulcerative Colitis. (2022) (0)
Longitudinal follow-up of bone mineral density in children with Crohn's disease from the time of diagnosis (2000) (0)
Su1790 – Infliximab Rescue Less Effective in Preventing Colectomy Early in the Course of Newly Diagnosed Ulcerative Colitis (2019) (0)
DOP65 Development and validation of the TUMMY-UC, a patient-reported outcome in pediatric Ulcerative Colitis: A multicenter prospective study (2022) (0)
976 Early Onset Crohn's Disease Exhibit Distinct Allele Architecture Differences and Reveal New IBD Loci (2013) (0)
Long-term Outcomes With Infliximab Treatment in Children With Crohnʼs Disease at a Single Centre: P-144 YI (2012) (0)
DOES AGE AT ONSET AFFECT IBD TREATMENT? (2006) (0)
A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease. (2023) (0)
O-23: Effectiveness of nutritional and anti-TNF therapy in North American children with active Crohn’s disease (2014) (0)
A236 ASSOCIATION OF STOOL METABOLOMIC PROFILE AND MICROBIOME COMPOSITION RISK SCORE WITH FUTURE ONSET OF CROHN’S DISEASE (2022) (0)
Sa2009 - Bioavailable Serum Vitamin D and Rectal Vitamin D Receptor Expression at Diagnosis in Pediatric Ulcerative Colitis: Associations with Disease Severity, Clinical Outcomes, and Rectal Patterns of Gene Expression (2018) (0)
Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone? (2021) (0)
Sa2070 An Assessment of the UlcerativE.ColiTis Endoscopic Index of Severity (UCEIS) and a Pancolonic Adaptation in Comparison to Clinical and Biochemical Markers of Disease Activity in Pediatric UlcerativE.ColiTis (2017) (0)
P-079: Comparison of quality of life among children treated with nutritional and anti-TNF therapies for active Crohn’s disease in North America (2014) (0)
135 THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS (2020) (0)
108 EXPERIENCE WITH SEMI-ELEMENTAL DIET THERAPY IN THE MANAGEMENT OF PAEDIATRIC CROHNʼS DISEASE (1994) (0)
RESOURCE UTILIZATION FOR CHILDREN WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE: 178 (2005) (0)
599 RELIABILITY AND VALIDITY ASSESSMENT OF ENDOSCOPIC ACTIVITY INDICES IN PEDIATRIC ULCERATIVE COLITIS (2020) (0)
Long‐term Outcomes With Infliximab Treatment in Children With Crohn's Disease at a Single Centre: O‐9 YI (2012) (0)
P396 Pharmacokinetics, immunogenicity and clinical outcomes of golimumab from the PURSUIT PEDS ulcerative colitis study long-term (through week 126) extension (2018) (0)
Reduced Neutrophil Granulocyte-Macrophage Colony Stimulating Factor Signaling is Associated with Granulocyte-Macrophage Colony Stimulating Factor Receptor Alpha Chain Gene Mutations and Stricturing Disease Complications in Pediatric Crohn Disease (2017) (0)
Su1655: ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN'S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY (2022) (0)
Identifying children diagnosed with inflammatory bowel disease using health administrative data: P-0071. (2008) (0)
The GTPase RAC1 is associated with inflammatory bowel disease (2011) (0)
P-047: The safety and effectiveness of carbon dioxide insufflation during colonoscopy in sedated pediatric patients with inflammatory bowel disease (2010) (0)
P089 Long ncRNA Landscape in the Rectum of Treatment Naïve Early Onset Ulcerative Colitis Highlights Association with Severity and Early and Late Disease Outcome, with Potential Role in Epithelial Metabolic Functions (2022) (0)
Patient-driven learning and symptom monitoring using handheld technology: A new perspective on education and counseling in the multidisciplinary Pediatric Inflammatory Bowel Disease Team (2011) (0)
Consensus guidelines for managing acute severe ulcerative colitis in children : a joint statement from ECCO , ESPGHAN , and the Pediatric IBD Porto Group Running title : Guidelines for managing acute severe colitis in children (2014) (0)
Magnetic Resonance Enterography indices for ileal Crohn's disease assessment: 1 Comparison between classical and machine-learning-based indices (2022) (0)
423 TARGETED ASSESSMENT OF MUCOSAL IMMUNE GENE EXPRESSION PREDICTS CLINICAL OUTCOMES IN CHILDREN WITH ULCERATIVE COLITIS (2021) (0)
Tu1866 - Outcomes with Adalimumab Therapy in Pediatric IBD: A Canadian Multicenter Inception Cohort Study (2018) (0)
90 Durability of Maintenance Infliximab Therapy in Children With Crohn's Disease: Are Gender and Concomitant Immunomodulators More Important Than We Thought? (2014) (0)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (0)
DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registry (2018) (0)
302 – Early Change in Fecal Calprotectin Predicts One Year Clinical Outcome in Children Newly Diagnosed with Ulcerative Colitis (2019) (0)
S2005 Clinical Effect and Changing Patterns of use of Methotrexate in the Treatment of Pediatric Crohn's Disease: A Multi-Center Experience (2010) (0)
Sa1999 Patient Related Outcomes and Disease Activity Indices in New Onset Pediatric Ulcerative Colitis: The PROTECT Study (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anne M. O. Griffiths?

Anne M. O. Griffiths is affiliated with the following schools:

Johns Hopkins University
University of Toronto
University of Pittsburgh

Anne M. O. Griffiths's Academic­Influence.com Rankings

Anne M. O. Griffiths's Degrees

Why Is Anne M. O. Griffiths Influential?

Anne M. O. Griffiths's Published Works

Published Works

What Schools Are Affiliated With Anne M. O. Griffiths?

Anne M. O. Griffiths's AcademicInfluence.com Rankings